199 related articles for article (PubMed ID: 19669161)
41. Gene conversion is a frequent mechanism of inactivation of the wild-type allele in cancers from MLH1/MSH2 deletion carriers.
Zhang J; Lindroos A; Ollila S; Russell A; Marra G; Mueller H; Peltomaki P; Plasilova M; Heinimann K
Cancer Res; 2006 Jan; 66(2):659-64. PubMed ID: 16423994
[TBL] [Abstract][Full Text] [Related]
42. Functional characterization of rare missense mutations in MLH1 and MSH2 identified in Danish colorectal cancer patients.
Christensen LL; Kariola R; Korhonen MK; Wikman FP; Sunde L; Gerdes AM; Okkels H; Brandt CA; Bernstein I; Hansen TV; Hagemann-Madsen R; Andersen CL; Nyström M; Ørntoft TF
Fam Cancer; 2009; 8(4):489-500. PubMed ID: 19697156
[TBL] [Abstract][Full Text] [Related]
43. Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 staining.
Mangold E; Pagenstecher C; Friedl W; Fischer HP; Merkelbach-Bruse S; Ohlendorf M; Friedrichs N; Aretz S; Buettner R; Propping P; Mathiak M
J Pathol; 2005 Dec; 207(4):385-95. PubMed ID: 16216036
[TBL] [Abstract][Full Text] [Related]
44. Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer.
Skeldon SC; Semotiuk K; Aronson M; Holter S; Gallinger S; Pollett A; Kuk C; van Rhijn B; Bostrom P; Cohen Z; Fleshner NE; Jewett MA; Hanna S; Shariat SF; Van Der Kwast TH; Evans A; Catto J; Bapat B; Zlotta AR
Eur Urol; 2013 Feb; 63(2):379-85. PubMed ID: 22883484
[TBL] [Abstract][Full Text] [Related]
45. MLH1 promoter germline-methylation in selected probands of Chinese hereditary non-polyposis colorectal cancer families.
Zhou HH; Yan SY; Zhou XY; Du X; Zhang TM; Cai X; Lu YM; Cai SJ; Shi DR
World J Gastroenterol; 2008 Dec; 14(48):7329-34. PubMed ID: 19109866
[TBL] [Abstract][Full Text] [Related]
46. Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer.
Casey G; Lindor NM; Papadopoulos N; Thibodeau SN; Moskow J; Steelman S; Buzin CH; Sommer SS; Collins CE; Butz M; Aronson M; Gallinger S; Barker MA; Young JP; Jass JR; Hopper JL; Diep A; Bapat B; Salem M; Seminara D; Haile R;
JAMA; 2005 Feb; 293(7):799-809. PubMed ID: 15713769
[TBL] [Abstract][Full Text] [Related]
47. Confirmation of single exon deletions in MLH1 and MSH2 using quantitative polymerase chain reaction.
Vaughn CP; Lyon E; Samowitz WS
J Mol Diagn; 2008 Jul; 10(4):355-60. PubMed ID: 18556772
[TBL] [Abstract][Full Text] [Related]
48. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer.
Wijnen JT; Vasen HF; Khan PM; Zwinderman AH; van der Klift H; Mulder A; Tops C; Møller P; Fodde R
N Engl J Med; 1998 Aug; 339(8):511-8. PubMed ID: 9709044
[TBL] [Abstract][Full Text] [Related]
49. Pathogenicity of missense and splice site mutations in hMSH2 and hMLH1 mismatch repair genes: implications for genetic testing.
Cravo M; Afonso AJ; Lage P; Albuquerque C; Maia L; Lacerda C; Fidalgo P; Chaves P; Cruz C; Nobre-Leitão C
Gut; 2002 Mar; 50(3):405-12. PubMed ID: 11839723
[TBL] [Abstract][Full Text] [Related]
50. Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancer.
Mangold E; Pagenstecher C; Friedl W; Mathiak M; Buettner R; Engel C; Loeffler M; Holinski-Feder E; Müller-Koch Y; Keller G; Schackert HK; Krüger S; Goecke T; Moeslein G; Kloor M; Gebert J; Kunstmann E; Schulmann K; Rüschoff J; Propping P
Int J Cancer; 2005 Sep; 116(5):692-702. PubMed ID: 15849733
[TBL] [Abstract][Full Text] [Related]
51. Partial duplications of the MSH2 and MLH1 genes in hereditary nonpolyposis colorectal cancer.
Baert-Desurmont S; Buisine MP; Bessenay E; Frerot S; Lovecchio T; Martin C; Olschwang S; Wang Q; Frebourg T
Eur J Hum Genet; 2007 Mar; 15(3):383-6. PubMed ID: 17228328
[TBL] [Abstract][Full Text] [Related]
52. Genetics of hereditary nonpolyposis colorectal cancer.
Akrami SM
Arch Iran Med; 2006 Oct; 9(4):381-9. PubMed ID: 17061614
[TBL] [Abstract][Full Text] [Related]
53. Reduced mRNA expression in paraffin-embedded tissue identifies MLH1- and MSH2-deficient colorectal tumours and potential mutation carriers.
Müller A; Zielinski D; Friedrichs N; Oberschmid B; Merkelbach-Bruse S; Schackert HK; Linnebacher M; von Knebel Doeberitz M; Büttner R; Rüschoff J;
Virchows Arch; 2008 Jul; 453(1):9-16. PubMed ID: 18581137
[TBL] [Abstract][Full Text] [Related]
54. Phenotype comparison of MLH1 and MSH2 mutation carriers in a cohort of 1,914 individuals undergoing clinical genetic testing in the United States.
Kastrinos F; Stoffel EM; Balmaña J; Steyerberg EW; Mercado R; Syngal S
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2044-51. PubMed ID: 18708397
[TBL] [Abstract][Full Text] [Related]
55. Association of colonic and endometrial carcinomas in Portuguese families with hereditary nonpolyposis colorectal carcinoma significantly increases the probability of detecting a pathogenic mutation in mismatch repair genes, primarily the MSH2 gene.
Lage PA; Albuquerque C; Sousa RG; Cravo ML; Salazar M; Francisco I; Maia L; Claro I; Suspiro A; Rodrigues P; Raposo H; Fidalgo PA; Nobre-Leitão C
Cancer; 2004 Jul; 101(1):172-7. PubMed ID: 15222003
[TBL] [Abstract][Full Text] [Related]
56. Characterization of MLH1 and MSH2 alternative splicing and its relevance to molecular testing of colorectal cancer susceptibility.
Genuardi M; Viel A; Bonora D; Capozzi E; Bellacosa A; Leonardi F; Valle R; Ventura A; Pedroni M; Boiocchi M; Neri G
Hum Genet; 1998 Jan; 102(1):15-20. PubMed ID: 9490293
[TBL] [Abstract][Full Text] [Related]
57. RNA splicing. The human splicing code reveals new insights into the genetic determinants of disease.
Xiong HY; Alipanahi B; Lee LJ; Bretschneider H; Merico D; Yuen RK; Hua Y; Gueroussov S; Najafabadi HS; Hughes TR; Morris Q; Barash Y; Krainer AR; Jojic N; Scherer SW; Blencowe BJ; Frey BJ
Science; 2015 Jan; 347(6218):1254806. PubMed ID: 25525159
[TBL] [Abstract][Full Text] [Related]
58. Four novel MSH2 and MLH1 frameshift mutations and occurrence of a breast cancer phenocopy in hereditary nonpolyposis colorectal cancer.
Caluseriu O; Cordisco EL; Viel A; Majore S; Nascimbeni R; Pucciarelli S; Genuardi M
Hum Mutat; 2001 Jun; 17(6):521. PubMed ID: 11385712
[TBL] [Abstract][Full Text] [Related]
59. Eight novel germline MLH1 and MSH2 mutations in hereditary non-polyposis colorectal cancer families from Spain.
Godino J; de La Hoya M; Diaz-Rubio E; Benito M; Caldés T
Hum Mutat; 2001 Dec; 18(6):549. PubMed ID: 11748856
[TBL] [Abstract][Full Text] [Related]
60. Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer.
Bapat BV; Madlensky L; Temple LK; Hiruki T; Redston M; Baron DL; Xia L; Marcus VA; Soravia C; Mitri A; Shen W; Gryfe R; Berk T; Chodirker BN; Cohen Z; Gallinger S
Hum Genet; 1999 Feb; 104(2):167-76. PubMed ID: 10190329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
